SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-018347
Filing Date
2024-06-27
Accepted
2024-06-27 17:02:53
Documents
2
Period of Report
2024-06-25

Document Format Files

Seq Description Document Type Size
1 form4-06272024_090647.html 4  
1 form4-06272024_090647.xml 4 4064
2 ex24-06272024_090648.htm EX-24 4777
  Complete submission text file 0001415889-24-018347.txt   10282
Mailing Address C/O DIAZ & ALTSCHUL CAPITAL 950 THIRD AVE NEW YORK NY 10022
Business Address
DIAZ REINALDO M (Reporting) CIK: 0001250086 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41855 | Film No.: 241080178

Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Issuer) CIK: 0001907108 (see all company filings)

IRS No.: 854012572 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)